Document:

Exhibit 10.15

 

FIRST AMENDMENT TO OFFICE LEASE

 

Circle Partnership, a limited partnership
("Landlord") and Targeted Medical Pharma, Inc. ("Tenant") hereby agree to amend the Office Lease dated February
4, 2009 (the "Lease") as follows. This First Amendment shall be effective on the date Tenant executes this First Amendment.

 

		1.	Term.

 

Paragraph 2 of the Lease entitled "Term"
shall be amended to provide that the term of the Lease shall be extended to February 28, 2015.

 

		2.	Rent. 

 

Commencing on March 1, 2012, the monthly rent
for the Demised Premises shall be $2.75 per square foot, which for the Demised Premises of 4794 square feet results in a monthly
rent of $13,183.50, subject to adjustments for the cost of living as provided in the Lease, and further adjustment in the event
Tenant exercises the Option to Extend. In addition, the base monthly rent for the storage space of 500 square feet as provided
in paragraph 65 of the Lease shall be increased to $700 per month, and thereafter shall also be subject to the annual adjustment
for the cost of living.

 

		3.	Bathroom. 

 

Tenant shall, at its sole cost and expense,
replace the bathroom it has removed from the first floor, which replacement bathroom shall conform to all existing laws, regulations,
and codes, and shall be comparable in design and amenities to the bathroom that was removed by Tenant. Tenant shall commence such
work within thirty (30) days after its execution of this Amendment and shall complete such work within one hundred twenty (120)
days thereafter.

 

		4.	Electrical Sub-Meter. 

 

Landlord reserves the right to sub-meter the
Demised Premises for electrical usage which will then be billed directly to Tenant and thereafter electrical costs shall no longer
be included in the calculation of common area charges to be paid by Tenant.

 

		5.	Right Of First Refusal.

 

(a)Landlord hereby grants to Tenant a
one-time right of first refusal, to be exercised in accordance with the following terms and conditions, to lease all or some portion
of space in the building that is contiguous to the Demised Premises (the "ROFR Space") in the event of receipt by Landlord
of the first written offer from a prospective new tenant to lease all or any portion of the ROFR Space that Landlord is ready and
willing to accept (an "Offer"). In the event Landlord receives an Offer, Landlord shall give Tenant written notice of
the receipt of such Offer (the "Offer Notice"), including a copy of the Offer, and the date on which the letting of the
ROFR Space (or such portion thereof as is specified in the Offer) is to commence pursuant to the terms of the Offer (the "Expansion
Space Occupancy Date"). Tenant shall thereupon have a right (the "Refusal Right") to Lease all, but not less than
all, of the ROFR Space identified in such Offer Notice (the "Expansion Space"), commencing no later than the Expansion
Space Occupancy Date on the same terms and condition as specified in the Offer, including any personal guarantees. The Refusal
Right is granted upon the following terms and conditions. Time is expressly made "of the essence" with respect to any
dates by which any action must be taken by Tenant.

 

    	-1-

    	 

    
 

(i)     Tenant shall give Landlord written notice of its election to exercise the Refusal Right, within five (5) business days after Landlord
delivers to Tenant the Offer Notice. 

 

(ii)     The Refusal Right shall be terminated and declared void in the event Tenant is in default under this Lease (without regard to
any cure or reinstatement rights which Tenant may have) either on the date Tenant gives exercises such Refusal Right, or unless
waived in writing by Landlord, on the Expansion Space Occupancy Date.

 

(iii)     In the event Tenant timely exercises the Refusal Right, Tenant and Landlord shall promptly execute and deliver a new amendment
adding the Expansion Space to the Premises on substantially the same terms and conditions as are contained in this Lease (the
"Expansion Space Amendment"), except that (1) the Expansion Space Amendment shall not contain the Refusal Right or any
similar right of first refusal or expansion right, and such rights shall not apply to the Expansion Space; and (2) the Term as
it applies to the Expansion Space shall be no less than the greater of (A) the remaining term of this Lease, or (B) the proposed
term of lease specified in the Offer; and (3) the terms and conditions set forth in the Offer with respect to rent, CAM charges,
triple net charges and all other financial obligations of the Tenant shall be as set forth in the Offer Notice (the "Expansion
Rent"). Tenant shall not be entitled to any tenant improvement/build out allowances that may be included in the Offer, nor
for any remuneration or credit in lieu of such allowances.

 

(iv)     In the event that Tenant does not timely or properly exercise the Refusal Right, the Refusal Right shall be terminated, void and
of no further force or effect, and Tenant shall have no rights with respect to the Expansion Space. Landlord may, at any time following
the expiration of the five (5) business day period described above, lease all or any portion of the Expansion Space to any third
party tenant on such economic terms and conditions as Landlord shall deem appropriate in its sole discretion. Tenant shall have
no rights or interests in any offers to lease the Expansion Space that Landlord receives after the initial Offer.

 

(v)     Monthly installments of Expansion Rent shall commence as of such Expansion Space Occupancy Date (prorated for the initial and final
months, if necessary). Tenant's Proportionate Share for the Expansion Space under the Expansion Space Amendment shall be determined
by dividing the number of rentable square feet in the Expansion Space by the total number of rentable square feet in the Building,
and Expansion Rent payments with respect to the Expansion Space shall also commence on the Expansion Space Occupancy Date (prorated
for the initial and final months, if necessary).

 

    	-2-

    	 

    
 

(vi)     If not earlier terminated pursuant to the foregoing terms, this Refusal Right shall terminate and be of no further force or effect
as of the Expiration Date of this Lease. Tenant hereby acknowledges and agrees that Landlord shall have no obligation to accept
any third party offer to Lease all or any portion of the Building, regardless of whether Landlord has received a Offer.

 

(vii)     The Refusal Right granted pursuant to this Section is personal to Tenant. If Tenant subleases more than 50% of the Demised Premises,
or assigns or otherwise transfers any interest under the Lease to any other person or entity prior to the exercise of this Refusal
Right (whether with or without Landlord's consent), this Refusal Right shall lapse and terminate and be of no further force or
effect. If Tenant subleases any portion of the Demised Premises or assigns or otherwise transfers any interest of Tenant under
the Lease to any entity or person (whether with or without Landlord's consent), after the exercise of this Refusal Right but prior
to the Expansion Space Occupancy Date, such exercise shall be deemed ineffective and this Refusal Right shall terminate and be
of no further force or effect 

 

		6.	Option To Extend Term Of Lease.

 

(a)Provided that Tenant has not breached
or defaulted under any of the terms of the Lease, Tenant may, subject to the conditions set forth in the Lease and this Amendment,
at its option (the "Option to Extend"), renew the term of the Lease (including any Expansion Space) for one (1) additional
five (5) year renewal period (the "Renewal Term") which shall commence immediately following the expiration of the initial
Term of the Lease, as extended (the "Initial Term"), provided, however, that such renewal option must be exercised only
by written notice given by Tenant, and received by Landlord, not more than twelve (12) months nor less than six (6) months prior
to the termination of the Initial Term. Strict compliance with the terms of exercise of this option is required, and there shall
be no implied or inferred exercises, regardless of the conduct or actions of Tenant or Landlord. Any renewal pursuant to the provisions
of this paragraph shall be on the terms and conditions contained in the Lease, as hereafter modified. In addition, in the event
that the Tenant has timely and properly exercised the Refusal Right, so that Expansion Space is included in the Demised Premises
pursuant to the Lease, the term of the Lease for the Expansion Space shall be automatically conformed to the Renewal Term, so that
all space then being rented by Tenant will be part of one and the same Lease with the same expiration date.

 

    	-3-

    	 

    
 

(b)The monthly Fixed Minimum Rent for
the first year of the Renewal Term shall be adjusted, upward only, to the fair market rental value of the Demised Premises as of
the commencement of the Renewal Term, provided, however, that the new monthly Fixed Minimum Rent shall be no less than one hundred
three percent (103%) of the monthly Fixed Minimum Rent then in effect, and the monthly Fixed Minimum Rent during the Renewal Term
shall be adjusted annually thereafter in accordance with Paragraph 8 of the Lease.

 

(c)Upon Tenant's timely and proper exercise
of the Option to Extend, Landlord and Tenant shall negotiate in good faith to reach agreement as to the fair market rental value
of the Demised Premises. If, after good faith negotiations, the parties are unable to reach agreement within thirty (30) days after
the date Tenant exercised the option, either party (in its discretion) may elect to proceed to arbitration, by delivering written
notice to the other party, as follows:

 

(i)     Within fifteen (15) days of such election, each party shall select a disinterested real estate broker who shall be actively engaged
and shall have been actively engaged in commercial leasing of properties comparable to the Demised Premises for a period of not
less than five (5) years. Within ten (10) days of the selection of both brokers, the two brokers shall then select a third broker
with the same qualifications; provided, however, that if either Landlord or Tenant shall not have appointed a broker as aforesaid
and shall have still failed to appoint such broker within five (5) days after written notice from the other party of such failure,
that party shall have waived its right to appoint a broker.

 

(ii)     Each of
the three brokers (or the sole broker if one party has waived its right to appoint a broker) shall make their own independent determination
of the fair market rental value of the Demised Premises, taking into account comparable space in the immediate vicinity of the
Demised Premises. The fair market rental value of the Demised Premises shall be an amount equal to the sum of the highest value,
the lowest value, and two times the middle value, divided by four (or the sole broker's determination if one party has waived its
right to appoint a broker). The determination of the fair market rental value shall at all times be subject to the monthly Fixed
Minimum Rent increase set forth in Section 5(b) above Each party shall be responsible for fees of the broker they select, and the
fees of the third broker shall be shared equally. Within ten (10) days of the final determination of the fair market rental value
of the Demised Premises, Tenant shall pay to Landlord any additional accrued amounts of the rental adjustments.

 

(iii)     At any time prior
to the determination by the broker(s), the parties may, by mutual agreement in writing, revoke the authority of the broker(s) if
they have otherwise reached agreement on the fair market rental value. The determination of the brokers (or the sole broker if
one party has waived its right to appoint a broker) shall be final and binding on the parties.

 

    	-4-

    	 

    
 

		7.	Security Deposit.

 

On March 1, 2012, Tenant shall deposit
with Landlord the sum of Four Thousand Eight Hundred Eighty-Two Dollars ($4,882) as additional Security Deposit pursuant to paragraph
5 of the Lease. The total Security Deposit made by Tenant will then be Twenty Thousand Dollars ($20,000). Upon any increase in
the monthly rent for any reason (including any cost-of-living adjustments or the addition of any Expansion Space) Tenant shall
promptly deposit with Landlord additional funds so that the total Security Deposit is increased proportionately to the increase
in monthly rent.

 

		8.	Miscellaneous.

 

All other terms and conditions of the Lease
shall remain in full force and effect.

 

[signatures on following page]

 

 

 

 

IN WITNESS WHEREOF, Landlord and Tenant
have executed this First Amendment to Lease at Los Angeles, California.

 

 

 

	Dated: November 14, 2011	 
	 	CIRCLE PARTNERSHIP, a limited partnership
	 	 
	 	 
	 	By:/s/ Sheila Goldman                                     
	 	           SHEILA GOLDMAN, General Partner
	 	 
	Dated: November 14, 2011	 
	 	TARGETED MEDICAL PHARMA, INC.
	 	 
	 	 
	 	By: William E. Shell                                            
	 	Its: CEO                                                                

 

    	-5-Exhibit 10.27

 

Please note parts of this Agreement and attachments are designated
with an “*” which indicates that material has been omitted and filed separately with the Securities and Exchange Commission
pursuant to a request for confidential treatment.

 

VENDOR AND EXCLUSIVITY AGREEMENT FOR
PROVISION OF MEDICAL FOODS

 

THIS VENDOR AND EXCLUSIVITY
AGREEMENT FOR PROVISION OF MEDICAL FOODS (“Agreement”) is entered into and executed effective as of August 15, 2011,
by and between Kalisthenics, Inc. (“Kalisthenics”), and Targeted Medical Pharma Inc. (“TMP”), with respect
to the following recitals:

 

A.                
Kalisthenics is a supplier of various medical products to skilled nursing facilities and other long-term care facilities
in California.

 

B.                
TMP a specialty pharmaceutical company that develops, manufactures and sell and proprietary nutrient pharmaceutical systems
including medical foods as such term is defined in Section 5(b) of the Orphan Drug Act (21 U.S.C. 360ee (b) (3); the “Act”))
(“Medical Foods”) and which are regulated by the United States Food and Drug Administration (“FDA”).

 

C.                
Kalisthenics desires to purchase exclusively from TMP and TMP desires to provide and sell exclusively to Kalisthenics for
distribution into skilled nursing facilities in California all of the Medical Foods set forth in Exhibit A attached hereto (“Medical
Foods Products”), for exclusive distribution as the sole distributor to skilled nursing facilities and other long-term care
facilities in California. Kalisthenics will have the non-exclusive rights for distribution outside of California.

 

D.                
TMP acknowledges that Kalisthenics will be expending significant efforts including time, work and money to establish this
distributorship business thus necessitating a vendor and exclusivity agreement as the sole distributor to skilled nursing facilities
and other long-term care facilities in California.

 

NOW, THEREFORE, the parties agree as follows:

 

1.                 
Kalisthenics Requirements of Medical Foods Products.

 

1.1.           
During the term of this Agreement, TMP shall provide and sell exclusively to Kalisthenics for distribution in California,
its full line of Medical Foods Products. TMP shall not distribute, provide or sell any of its Medical Foods Products to any skilled
nursing or long-term care facility or other provider, distributor or pharmacy other than Kalisthenics, as the sole distributor
for TMP, without the prior written consent of Kalisthenics in California..

 

1.2.           
In the event TMP provides Medical Foods Products to any skilled nursing or long-term care facility or other provider, distributor
or pharmacy, Kalisthenics has the right to request that TMP discontinue providing product to them.

 

1.3.           
The price list for each of the Medical Foods Products is set forth in Exhibit A attached hereto.

 

1.4.           
Kalisthenics acknowledges that its usual total monthly requirements of the Medical Foods Products are set forth in Exhibit
A; provided, however, TMP acknowledges and agrees that (a) Kalisthenics guarantees that it will make an upfront of Medical Foods
Products equal to one year’s supply (the quantity to be determined by the parties), (b) Kalisthenics will purchase minimum
amounts of the Medical Foods Products each month during the term of this Agreement as specified in Exhibit A, and (c) Kalisthenics’
monthly requirements may change from time to time. Notwithstanding the foregoing, in the event that there will be a significant
change in Kalisthenics’ requirements for the Medical Foods Products, Kalisthenics will use commercially reasonable efforts
to provide TMP with notice of such change.

 

    	-1-

    	 

    
 

1.5.           
Kalisthenics will provide TMP with its order(s) for its Medical Foods Products Requirements on or before the 15th
day of each calendar month during the term hereof and TMP shall deliver the Medical Foods Products ordered by Kalisthenics to the
Kalisthenics facility on the days of each month and during the times set forth in Exhibit B.

 

2.                 
Invoice; Payment. On or before the 15th day of each calendar month during the term hereof, TMP shall deliver
to Kalisthenics a detailed invoice for all Medical Foods Products purchased by Kalisthenics and delivered by TMP as set forth herein
during the immediately preceding calendar month. Kalisthenics shall pay the amount of each such invoice to TMP within forty-five
(45) days following Kalisthenics’ receipt thereof on a “45-day net” basis.

 

3.                 
Representations and Warrantees of TMP.

 

3.1.           
TMP hereby represents and warrants that at all times during the term of this Agreement (a) all Medical Foods Products have
been manufactured in strict accordance with all applicable federal and state laws, regulations and rules including, without limitation,
the Act and all other requirements of the FDA, and (ii) it is in compliance with the requirements of the FDA Compliance Program
for Medical Foods – Import and Domestic.

 

3.2.           
TMP will disclose to and notify Kalisthenics of any communications made to TMP with respect to product purchase by any skilled
nursing or long-term care facility or other provider, distributor or pharmacy within three (3) days of such communication.

 

4.                 
Term and Termination.

 

4.1.           
The initial term of this Agreement shall be five (5) years commencing on July 1, 2011, and ending on June 30, 2016 (“Initial
Term”), provided that following the Initial Term both parties will negotiate, in good faith, a new 5-year agreement, provided
that Kalisthenics has been and is fulfilling its purchasing obligations hereunder Addendum A. New minimum order requirements to
maintain the Kalisthenics exclusivity will be negotiated by the parties on or before August 1st of each year,

 

4.2.           
Either party may terminate this Agreement for “cause” which, for purposes of this Agreement, shall include,
but not be limited to, the occurrence of one or more of following events:

 

a.                  
The other party is in breach of any material term or condition of this Agreement, and such breach has not been cured within
ten (10) days following notice of such breach.

 

    	-2-

    	 

    
 

b.                 
Any representation or warranty by TMP is false or was false at the time it was originally made.

 

5.                 
Jeopardy. Notwithstanding anything to the contrary contained in this Agreement, in the event the performance by either
party hereto of any term, covenant, condition or provision of this Agreement should jeopardize Kalisthenics’ participation
in Medicare, Medi-Cal, or other reimbursement or payment programs, or if for any other reason such performance should be in violation
of any statute, ordinance, or be otherwise deemed illegal, or be deemed unethical by any recognized body, agency, or association
in the medical long-term healthcare fields, the affected party may at its option terminate this Agreement immediately.

 

6.                 
Liquidated Damages. In the event TMP sells or provides Medical Foods Products to any skilled nursing or long-term
care facility or other provider, distributor or pharmacy other than Kalisthenics, TMP will pay Kalisthenics, because damages in
connection with such a breach by TMP are nearly impossible to calculate, liquidated damages equal to (i) lost revenue or potential
profit had Kalisthenics been able to sell such Medical Foods Products, and (ii) TMP’s gross profits made on the sales of
such Medical Foods Products.

 

7.                 
Verification of Costs. If and to the extent required by Section 1395x(v)(1)(A)(I) of Title 42 of the United States
Code, until the expiration of four (4) years after the termination of this Agreement, TMP shall make available, upon written request
to the Secretary of the United States Department of Health and Human Services, or upon request to the Comptroller General of the
United States General Accounting Office, or any of their duly authorized representatives, a copy of this Agreement and such books,
documents and records as are necessary to certify the nature and extent of the costs of the services provided by TMP under this
Agreement.

 

8.                 
Notices. Whenever under the terms of this Agreement written notice is required or permitted to be given by any party
to any other party, such notice shall be deemed to have been sufficiently given (i) on the date of delivery if personally delivered,
or (ii) one (1) day following deposit with a national overnight courier service, or (iii) two (2) days following deposit in the
United States Mail, certified or registered mail, return-receipt-requested, addressed to the party to whom it is to be given at
the address specified on the signature page hereof and to Kalisthenics’ attorney at the following address: Hooper, Lundy
& Bookman, P.C., 1875 Century Park East, Suite 1600, Los Angeles, California 90067, Attn: Mark Johnson. Either party hereto
may change its respective address by written notice in accordance with this Section.

 

9.                 
Relationship of Parties. Neither party is for any purpose an agent, partner or employee of the other; and this Agreement
does not constitute a joint venture between the parties. For all purposes under this Agreement the parties are independent contractors.

 

10.             
Force Majeure. If either party fails to perform its obligations hereunder (except for the obligation to pay money)
because of strikes, accidents, acts of God, weather conditions, or action or inaction of any governmental body or other proper
authority or other causes beyond such party’s control, then such failure to perform will not be deemed a default hereunder
and will be excused without penalty until such time as such party is capable of performing.

 

    	-3-

    	 

    
 

11.             
Entirety; Amendment. This Agreement contains the sole and entire agreement between the parties with respect to the
subject matter hereof and shall supersede any and all prior agreements between the parties with respect to such subject matter.
This Agreement may not be amended except by a writing signed by both parties.

 

12.             
Waiver. No waiver of any covenant, condition or limitation contained herein shall be valid unless in writing and
duly executed by the party to be charged therewith. The waiver of any covenant, condition, or limitation contained herein, or of
the breach thereof, shall not be construed as a waiver of any other covenant, condition, limitation or breach, or a waiver of the
same covenant, condition, limitation or breach in any other instance.

 

13.             
Assignment. TMP shall not have the right to assign this Agreement nor any of its rights or obligations hereunder,
and any attempted or purported assignment shall be null and void and of no effect.

 

14.             
Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed to be an original.

 

15.             
Governing Law. This Agreement shall be governed by the laws of the State of California.

 

16.             
First order of * Units at $* per unit. Kalisthenics shall pay the amount of each such invoice to TMP within one
hundred eighty (180) days following Kalisthenics receipt thereof.

 

17.             
If Kalisthenics does not meet the minimum purchase order as outlined in Addendum A attached to this contract, TMP must give
Kalisthenics advance notice in writing to cancel the exclusivity agreement. Kalisthenics will then have 60 days to cure by buying
the required amount of product.

 

    	-4-

    	 

    
 

IN WITNESS WHEREOF, the parties hereto
have executed this Agreement as of the date first set forth above.

 

	Kalisthenics:	KALISTHENICS, INC.
	 	 
	 	 	 
	 	By: /s/ David Zeffren                                               
	 	       David Zeffren, Senior Vice President
	 	 
	 	Address:	7846 Commonwealth Avenue
	 	 	Buena Park, CA 90621-2423
	 	 	 
	 	 	 
	TMP:	TARGETED MEDICAL PHARMA INC.
	 	 
	 	 	 
	 	By: /s/ William Shell                                            
	 	        William Shell, CEO
	 	 
	 	Address:	2980 Beverly Glen Circle, Suite 301
	 	 	Los Angeles, CA 90077

 

    	-5-

    	 

    
 

EXHIBIT A

Medical Foods Products

 

	Medical Foods Products – Item Nos.	Price per unit	Kalisthenics’ Usual Total Monthly Requirements
	 	 	 
	Theramine	*	*
	 	 	 
	Sentra AM	*	*
	 	 	 
	Sentra PM	*	*
	 	 	 
	GABAdone	*	*
	 	 	 
	Hypertensa	*	*
	 	 	 
	Lister V	*	*
	 	 	 
	AppTrim / AppTrim-D	*	*

 

    	-6-

    	 

    
 

EXHIBIT B

Delivery Schedule

 

LOCATION:

 

Kalisthenics Facility

 

7846 Commonwealth Ave

Buena Park, CA 90621-2423

Phone: 888-314-0555

 

Delivery Schedule:

 

    	-7-

    	 

    
 

Addendum A: Minimum Purchase Orders

 

	Month	Number of Units
	 	 
	September, 2011	*
	 	 
	October, 2011	*
	 	 
	November, 2011	*
	 	 
	December, 2011	*
	 	 
	January, 2012	*
	 	 
	February, 2012	*
	 	 
	March, 2012	*
	 	 
	April, 2012	*
	 	 
	May, 2012	*
	 	 
	June, 2012	*
	 	 
	July, 2012	*
	 	 
	August, 2012	*

 

Initials_______

           _______

 

    	-8-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00202-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00202-of-00352.parquet"}]]